Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Clinical trial NCT06628908 · RECRUITING
Trial details
- NCT number
- NCT06628908
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-05-31
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.